Anne S. Drapeau - 16 Sep 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Anne S. Drapeau, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
16 Sep 2021
Net transactions value
$0
Form type
4
Filing time
24 Sep 2021, 17:06:39 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 16 Sep 2021 Common Stock 30,000 $26.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option shall vest over 36 months, 1/3 of which will vest on September 16, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date